TENAX THERAPEUTICS, INC. Interest on Convertible Debt, Net of Tax
TENAX THERAPEUTICS, INC. (TENX) reported Interest on Convertible Debt, Net of Tax of $0 for the 12-month period ending 2015-04-30, per its 10-K filed 2015-07-14.
Discontinued › Notes
us-gaap:InterestOnConvertibleDebtNetOfTax · last filed 2016-03-14
- TENAX THERAPEUTICS, INC. interest on convertible debt, net of tax for the quarter ending 2015-04-30 was $0.00, a 100.00% decline year-over-year.
- TENAX THERAPEUTICS, INC. interest on convertible debt, net of tax for the quarter ending 2015-01-31 was $0.00.
- TENAX THERAPEUTICS, INC. interest on convertible debt, net of tax for the quarter ending 2014-10-31 was $0.00.
- TENAX THERAPEUTICS, INC. interest on convertible debt, net of tax for the quarter ending 2014-07-31 was $0.00.
- TENAX THERAPEUTICS, INC. interest on convertible debt, net of tax for fiscal 2015 was $0.00.
- TENAX THERAPEUTICS, INC. interest on convertible debt, net of tax for fiscal 2014 was $0.00.
- TENAX THERAPEUTICS, INC. interest on convertible debt, net of tax for fiscal 2013 was -$1.38M.
- TENAX THERAPEUTICS, INC. interest on convertible debt, net of tax for fiscal 2012 was -$3.82M.
| Period end | Interest on Convertible Debt, Net of Tax 3 month | Interest on Convertible Debt, Net of Tax 3 month as first filed | Interest on Convertible Debt, Net of Tax 6 month | Interest on Convertible Debt, Net of Tax 9 month | Interest on Convertible Debt, Net of Tax 12 month |
|---|---|---|---|---|---|
| 2015-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-14 | $0.00 derived: sum of 2 quarters · filed 2015-07-14 | $0.00 derived: sum of 3 quarters · filed 2015-07-14 | $0.00 10-K · filed 2015-07-14 | |
| 2015-01-31 | $0.00 10-Q · filed 2015-03-17 | $0.00 derived: sum of 2 quarters · filed 2015-03-17 | $0.00 10-Q · filed 2015-03-17 | $133.36K derived: sum of 4 quarters · filed 2015-07-14 | |
| 2014-10-31 | $0.00 10-Q · filed 2014-12-15 | $0.00 10-Q · filed 2014-12-15 | $133.36K derived: sum of 3 quarters · filed 2015-07-14 | $95.26K derived: sum of 4 quarters · filed 2015-07-14 | |
| 2014-07-31 | $0.00 10-Q · filed 2014-09-15 | $133.36K derived: sum of 2 quarters · filed 2015-07-14 | $95.26K derived: sum of 3 quarters · filed 2015-07-14 | $0.00 derived: sum of 4 quarters · filed 2015-07-14 | |
| 2014-04-30 | $133.36K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-14 | $95.26K derived: sum of 2 quarters · filed 2015-07-14 | $0.00 derived: sum of 3 quarters · filed 2015-07-14 | $0.00 10-K · filed 2015-07-14 | |
| 2014-01-31 | -$38.10K 10-Q · filed 2015-03-17 | -$133.36K derived: sum of 2 quarters · filed 2015-03-17 | -$133.36K 10-Q · filed 2015-03-17 | -$2.10M derived: sum of 4 quarters · filed 2016-03-14 | |
| 2013-10-31 | -$95.26K 10-Q · filed 2014-12-15 | -$95.26K 10-Q · filed 2014-12-15 | -$2.06M derived: sum of 3 quarters · filed 2016-03-14 | -$4.56M derived: sum of 4 quarters · filed 2016-03-14 | |
| 2013-07-31 | -$3.08M 10-Q · filed 2014-09-15 | -$1.97M derived: sum of 2 quarters · filed 2016-03-14 | -$4.46M derived: sum of 3 quarters · filed 2016-03-14 | -$7.40M derived: sum of 4 quarters · filed 2016-03-14 | |
| 2013-04-30 | $1.11M derived: 10-KT 12 month − 10-Q 9 month · filed 2016-03-14 | -$1.38M derived: sum of 2 quarters · filed 2016-03-14 | -$4.32M derived: sum of 3 quarters · filed 2016-03-14 | -$1.38M 10-KT · filed 2016-03-14 | |
| 2013-01-31 | -$2.50M 10-Q · filed 2014-03-17 | -$5.44M derived: sum of 2 quarters · filed 2014-03-17 | -$2.50M 10-Q · filed 2014-03-17 | -$8.37M derived: sum of 4 quarters · filed 2014-03-17 | |
| 2012-10-31 | -$2.94M 10-Q · filed 2013-12-17 | -$2.94M 10-Q · filed 2012-12-14 | -$2.94M 10-Q · filed 2013-12-17 | -$5.88M derived: sum of 3 quarters · filed 2013-12-17 | -$10.13M derived: sum of 4 quarters · filed 2013-12-17 |
| 2012-07-31 | -$3.38M 10-Q · filed 2013-09-17 | -$2.94M derived: sum of 2 quarters · filed 2013-09-17 | -$7.19M derived: sum of 3 quarters · filed 2013-09-17 | -$11.83M derived: sum of 4 quarters · filed 2013-09-17 | |
| 2012-04-30 | $440.49K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-26 | -$3.82M derived: sum of 2 quarters · filed 2013-06-26 | -$8.45M derived: sum of 3 quarters · filed 2013-06-26 | -$3.82M 10-K · filed 2013-06-26 | |
| 2012-01-31 | -$4.26M 10-Q · filed 2013-03-18 | -$8.90M derived: sum of 2 quarters · filed 2013-03-18 | -$4.26M 10-Q · filed 2013-03-18 | ||
| 2011-10-31 | -$4.64M 10-Q · filed 2012-12-14 | -$4.64M 10-Q · filed 2012-12-14 | |||
| 2011-07-31 | -$5.07M 10-Q · filed 2012-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |